Press Releases

October 7, 2021
Accolade Announces Results for Fiscal Second Quarter 2022
Fiscal second quarter 2022 revenue of $73.3 million, a 99% increase compared to fiscal second quarter 2021 revenue of $36.8 million  Introduced Personalized Healthcare category, focused on human relationships and personalization using data to enable value-based care Launched Accolade One and
Additional Formats
September 20, 2021
Accolade Invites Media, Investors and General Public to Opening of Evolve21
Accolade executives to make announcement during the opening keynotes at Evolve21, the company's annual customer event. SEATTLE , Sept. 20, 2021 /PRNewswire/ -- WHAT:             Accolade, Inc. (Nasdaq: ACCD) the company that provides millions of people and their families with exceptional healthcare
Additional Formats
September 16, 2021
Accolade to Announce Fiscal Second Quarter 2022 Financial Results
SEATTLE, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced that it will release fiscal second quarter 2022 financial results on Thursday, October 7, 2021, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m.
Additional Formats
September 7, 2021
Accolade to Participate in Upcoming Investor Conferences
SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, will participate in the following upcoming investor conferences: Morgan Stanley Virtual Global Healthcare Conference including a fireside chat
Additional Formats
Displaying 1 - 10 of 30

Search Investor Relations